nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CHRM3—nephrolithiasis	0.847	1	CbGaD
Cevimeline—CHRM3—ureter—nephrolithiasis	0.0177	0.407	CbGeAlD
Cevimeline—Sialoadenitis—Hydrochlorothiazide—nephrolithiasis	0.00508	0.0464	CcSEcCtD
Cevimeline—Cardiac murmur—Hydrochlorothiazide—nephrolithiasis	0.004	0.0366	CcSEcCtD
Cevimeline—FMO1—nephron tubule—nephrolithiasis	0.00376	0.0866	CbGeAlD
Cevimeline—FMO1—renal system—nephrolithiasis	0.00342	0.0788	CbGeAlD
Cevimeline—FMO1—kidney—nephrolithiasis	0.0033	0.0761	CbGeAlD
Cevimeline—FMO1—cortex of kidney—nephrolithiasis	0.00322	0.0742	CbGeAlD
Cevimeline—CYP3A4—urine—nephrolithiasis	0.00315	0.0727	CbGeAlD
Cevimeline—CYP2D6—urine—nephrolithiasis	0.0031	0.0715	CbGeAlD
Cevimeline—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.00297	0.0271	CcSEcCtD
Cevimeline—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.00269	0.0245	CcSEcCtD
Cevimeline—Trauma—Hydrochlorothiazide—nephrolithiasis	0.00261	0.0238	CcSEcCtD
Cevimeline—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.00236	0.0216	CcSEcCtD
Cevimeline—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00221	0.0202	CcSEcCtD
Cevimeline—Toothache—Hydrochlorothiazide—nephrolithiasis	0.00204	0.0186	CcSEcCtD
Cevimeline—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.00186	0.017	CcSEcCtD
Cevimeline—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.00172	0.0157	CcSEcCtD
Cevimeline—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00153	0.014	CcSEcCtD
Cevimeline—CHRM3—renal system—nephrolithiasis	0.0014	0.0324	CbGeAlD
Cevimeline—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00137	0.0125	CcSEcCtD
Cevimeline—CHRM3—kidney—nephrolithiasis	0.00136	0.0313	CbGeAlD
Cevimeline—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00134	0.0122	CcSEcCtD
Cevimeline—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00134	0.0122	CcSEcCtD
Cevimeline—Gout—Hydrochlorothiazide—nephrolithiasis	0.00133	0.0121	CcSEcCtD
Cevimeline—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00131	0.012	CcSEcCtD
Cevimeline—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0013	0.0118	CcSEcCtD
Cevimeline—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00127	0.0116	CcSEcCtD
Cevimeline—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00126	0.0115	CcSEcCtD
Cevimeline—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00126	0.0115	CcSEcCtD
Cevimeline—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00122	0.0111	CcSEcCtD
Cevimeline—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00117	0.0107	CcSEcCtD
Cevimeline—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00113	0.0104	CcSEcCtD
Cevimeline—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00112	0.0102	CcSEcCtD
Cevimeline—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00104	0.00946	CcSEcCtD
Cevimeline—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00937	CcSEcCtD
Cevimeline—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00928	CcSEcCtD
Cevimeline—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00101	0.0092	CcSEcCtD
Cevimeline—Injury—Hydrochlorothiazide—nephrolithiasis	0.00098	0.00895	CcSEcCtD
Cevimeline—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.000963	0.00879	CcSEcCtD
Cevimeline—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.000959	0.00876	CcSEcCtD
Cevimeline—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.000954	0.00872	CcSEcCtD
Cevimeline—Thirst—Hydrochlorothiazide—nephrolithiasis	0.000946	0.00864	CcSEcCtD
Cevimeline—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.000946	0.00864	CcSEcCtD
Cevimeline—Purpura—Hydrochlorothiazide—nephrolithiasis	0.000934	0.00854	CcSEcCtD
Cevimeline—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.000927	0.00846	CcSEcCtD
Cevimeline—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.000904	0.00826	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.000901	0.00823	CcSEcCtD
Cevimeline—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.000901	0.00823	CcSEcCtD
Cevimeline—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.000887	0.0081	CcSEcCtD
Cevimeline—Migraine—Hydrochlorothiazide—nephrolithiasis	0.000887	0.0081	CcSEcCtD
Cevimeline—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.000869	0.00794	CcSEcCtD
Cevimeline—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.000853	0.00779	CcSEcCtD
Cevimeline—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.000826	0.00754	CcSEcCtD
Cevimeline—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.000823	0.00751	CcSEcCtD
Cevimeline—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00082	0.00749	CcSEcCtD
Cevimeline—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.000797	0.00728	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000794	0.00726	CcSEcCtD
Cevimeline—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.000794	0.00726	CcSEcCtD
Cevimeline—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.000784	0.00716	CcSEcCtD
Cevimeline—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.000778	0.00711	CcSEcCtD
Cevimeline—CYP3A4—renal system—nephrolithiasis	0.000771	0.0178	CbGeAlD
Cevimeline—CYP2D6—renal system—nephrolithiasis	0.000759	0.0175	CbGeAlD
Cevimeline—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.000758	0.00693	CcSEcCtD
Cevimeline—CYP3A4—kidney—nephrolithiasis	0.000746	0.0172	CbGeAlD
Cevimeline—CYP2D6—kidney—nephrolithiasis	0.000734	0.0169	CbGeAlD
Cevimeline—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000728	0.00665	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.000723	0.00661	CcSEcCtD
Cevimeline—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.000719	0.00657	CcSEcCtD
Cevimeline—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000717	0.00655	CcSEcCtD
Cevimeline—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.000711	0.00649	CcSEcCtD
Cevimeline—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.000708	0.00647	CcSEcCtD
Cevimeline—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000702	0.00641	CcSEcCtD
Cevimeline—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.000698	0.00638	CcSEcCtD
Cevimeline—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.000684	0.00625	CcSEcCtD
Cevimeline—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00068	0.00621	CcSEcCtD
Cevimeline—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00068	0.00621	CcSEcCtD
Cevimeline—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000675	0.00616	CcSEcCtD
Cevimeline—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.000675	0.00616	CcSEcCtD
Cevimeline—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000662	0.00604	CcSEcCtD
Cevimeline—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.000655	0.00598	CcSEcCtD
Cevimeline—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.000651	0.00595	CcSEcCtD
Cevimeline—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000648	0.00592	CcSEcCtD
Cevimeline—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.000625	0.00571	CcSEcCtD
Cevimeline—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00062	0.00566	CcSEcCtD
Cevimeline—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000618	0.00565	CcSEcCtD
Cevimeline—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.000614	0.00561	CcSEcCtD
Cevimeline—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0006	0.00548	CcSEcCtD
Cevimeline—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000581	0.00531	CcSEcCtD
Cevimeline—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000578	0.00528	CcSEcCtD
Cevimeline—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000557	0.00508	CcSEcCtD
Cevimeline—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.000551	0.00503	CcSEcCtD
Cevimeline—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000534	0.00488	CcSEcCtD
Cevimeline—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000531	0.00485	CcSEcCtD
Cevimeline—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000525	0.00479	CcSEcCtD
Cevimeline—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000521	0.00476	CcSEcCtD
Cevimeline—Tremor—Hydrochlorothiazide—nephrolithiasis	0.000508	0.00464	CcSEcCtD
Cevimeline—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000503	0.0046	CcSEcCtD
Cevimeline—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.000501	0.00458	CcSEcCtD
Cevimeline—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000498	0.00455	CcSEcCtD
Cevimeline—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000489	0.00447	CcSEcCtD
Cevimeline—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000487	0.00445	CcSEcCtD
Cevimeline—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000486	0.00444	CcSEcCtD
Cevimeline—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000486	0.00443	CcSEcCtD
Cevimeline—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000479	0.00438	CcSEcCtD
Cevimeline—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000477	0.00435	CcSEcCtD
Cevimeline—Cough—Hydrochlorothiazide—nephrolithiasis	0.000473	0.00432	CcSEcCtD
Cevimeline—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000462	0.00422	CcSEcCtD
Cevimeline—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000462	0.00422	CcSEcCtD
Cevimeline—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000462	0.00422	CcSEcCtD
Cevimeline—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00046	0.0042	CcSEcCtD
Cevimeline—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000456	0.00417	CcSEcCtD
Cevimeline—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000446	0.00408	CcSEcCtD
Cevimeline—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000443	0.00404	CcSEcCtD
Cevimeline—Shock—Hydrochlorothiazide—nephrolithiasis	0.000436	0.00398	CcSEcCtD
Cevimeline—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000433	0.00396	CcSEcCtD
Cevimeline—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000432	0.00395	CcSEcCtD
Cevimeline—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000428	0.00391	CcSEcCtD
Cevimeline—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000422	0.00385	CcSEcCtD
Cevimeline—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000414	0.00378	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000403	0.00368	CcSEcCtD
Cevimeline—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0004	0.00366	CcSEcCtD
Cevimeline—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000397	0.00363	CcSEcCtD
Cevimeline—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000395	0.0036	CcSEcCtD
Cevimeline—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000394	0.00359	CcSEcCtD
Cevimeline—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00039	0.00356	CcSEcCtD
Cevimeline—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000385	0.00351	CcSEcCtD
Cevimeline—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000382	0.00349	CcSEcCtD
Cevimeline—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000379	0.00346	CcSEcCtD
Cevimeline—Pain—Hydrochlorothiazide—nephrolithiasis	0.000379	0.00346	CcSEcCtD
Cevimeline—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000365	0.00333	CcSEcCtD
Cevimeline—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000362	0.00331	CcSEcCtD
Cevimeline—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000352	0.00321	CcSEcCtD
Cevimeline—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00035	0.0032	CcSEcCtD
Cevimeline—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00035	0.0032	CcSEcCtD
Cevimeline—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000326	0.00298	CcSEcCtD
Cevimeline—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000318	0.0029	CcSEcCtD
Cevimeline—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000313	0.00286	CcSEcCtD
Cevimeline—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000303	0.00277	CcSEcCtD
Cevimeline—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000293	0.00267	CcSEcCtD
Cevimeline—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000281	0.00257	CcSEcCtD
Cevimeline—Rash—Hydrochlorothiazide—nephrolithiasis	0.000279	0.00255	CcSEcCtD
Cevimeline—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000279	0.00255	CcSEcCtD
Cevimeline—Headache—Hydrochlorothiazide—nephrolithiasis	0.000277	0.00253	CcSEcCtD
Cevimeline—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000263	0.0024	CcSEcCtD
